News

Blood Vesicles May Help ID Atypical Parkinsonism vs Parkinson’s

Blood levels of neuron-derived small vesicles containing alpha-synuclein and tau protein clumps — both linked to neurodegenerative disorders — can accurately distinguish between people with Parkinson’s disease and those with atypical parkinsonism, a study found. When isolated from the blood, these nerve cell vesicles may “provide a window…

Top 10 Parkinson’s Disease Stories of 2022

Throughout 2022, Parkinson’s News Today brought you daily coverage of the latest scientific breakthroughs and treatment advancements related to Parkinson’s disease. Here are the 10 most-read articles of 2022, with a brief description of what made them interesting and relevant to the Parkinson’s community. We look forward to continuing…

Sleep Benefit May Be Explained by ‘Direct Neurochemical Evidence’

Sleep benefit — a poorly understood phenomenon where people with Parkinson’s disease have fewer symptoms upon waking up — is associated with higher levels of dopamine transporter proteins in a region of the brain called the putamen, a study shows. These findings “are meaningful because they provide direct neurochemical…

Study Challenges View of How Alpha-synuclein Drives Parkinson’s

Alpha-synuclein clumps’ toxic effects — a hallmark of Parkinson’s disease — are independent of the production of the protein by neurons themselves, according to a study in mice. In mice lacking alpha-synuclein, exposure to toxic protein clumping resulted in comparable neurodegeneration, which was found to be related to the…